# Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)

> **NCT05610072** · EARLY_PHASE1 · COMPLETED · sponsor: **William Stoops** · enrollment: 12 (actual)

## Conditions studied

- Cocaine Use Disorder
- Opioid Use Disorder
- Stimulant Use Disorder

## Interventions

- **DRUG:** n-acetylcysteine
- **DRUG:** Hydromorphone
- **DRUG:** Placebo n-acetylcystine
- **DRUG:** Placebo hydromorphone

## Key facts

- **NCT ID:** NCT05610072
- **Lead sponsor:** William Stoops
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-15
- **Primary completion:** 2026-03-27
- **Final completion:** 2026-03-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05610072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05610072, "Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05610072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*